awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38005013-266FB1B5-3E5B-4AD5-8B6F-F0C4849E0DB9
Q38005013-266FB1B5-3E5B-4AD5-8B6F-F0C4849E0DB9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38005013-266FB1B5-3E5B-4AD5-8B6F-F0C4849E0DB9
Preservation of myocardium during coronary artery bypass surgery.
P2860
Q38005013-266FB1B5-3E5B-4AD5-8B6F-F0C4849E0DB9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38005013-266FB1B5-3E5B-4AD5-8B6F-F0C4849E0DB9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4df69861abc8efdc1f7b59ea72a5ed894236c5f7
P2860
Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass.